Trump FDA Tackles Opioid Crisis With New Medication Approval
1 sourceUpdated Jul 2, 2026
The U.S. Food and Drug Administration approved a new over-the-counter naloxone nasal spray on Tuesday in an effort to combat the nation’s opioid overdose crisis. Rextovy is a naloxone hydrochloride nasal spray that can…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup